Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 47, Issue 2, February 2022, Pages 99-165
 
MONOGRAPHS
 
  
 Entospletinib.
Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy.
Wei, Z-H., Koya, J., Dong, X-D., Reznik, S.E., Chen, Z.-S.
Drugs Fut 2022, 47(2): 99
Summary | Full Text: PDF 
 
  
  
 Nirsevimab.
Anti-glycoprotein F (respiratory syncytial virus) monoclonal antibody, Prevention of respiratory syncytial virus-associated illness.
Akhir, A., Dasgupta, A., Chopra, S.
Drugs Fut 2022, 47(2): 109
Summary | Full Text: PDF 
 
  
  
 Zimberelimab.
Anti-programmed cell death protein 1 (PD-1) monoclonal antibody, Treatment of Hodgkin lymphoma, Treatment of advanced solid tumors.
Sahu, M., Choe, J.H.
Drugs Fut 2022, 47(2): 115
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLE
 
  
 Rationale of ferroportin inhibition for Β-thalassemia management.
Asadov, C., Aliyeva, G., Shirinova, A., Alimirzoyeva, Z.
Drugs Fut 2022, 47(2): 123
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the Move.
Torramade, E., Molas, G.
Drugs Fut 2022, 47(2): 131
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 American Society of Human Genetics Annual Meeting. Virtual – October 18-22, 2021.
Fernandez, N.
Drugs Fut 2022, 47(2): 147
Summary | Full Text: PDF 
 
  
  
 European Society of Gene and Cell Therapy (ESGCT) – 28th Annual Meeting. Virtual – October 19-22, 2021.
Suria, R.M., Verges, C.
Drugs Fut 2022, 47(2): 151
Summary | Full Text: PDF 
 
  
  
 Kidney Week 2021. Virtual – November 4-7, 2021.
Sudha, P.
Drugs Fut 2022, 47(2): 155
Summary | Full Text: PDF 
 
  
  
 Society for Immunotherapy of Cancer (SITC) – 36th Annual Meeting. Virtual – November 10-14, 2021.
Toldra, J.
Drugs Fut 2022, 47(2): 161
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences